Access cutting-edge retinitis pigmentosa treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.
Access retinitis pigmentosa specialists in Durham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related retinitis pigmentosa treatment provided free
The purpose of this Phase 2 Study is to see if the investigational study drug, laruparetigene zovaparvovec, also known as AGTC-501, given in both eyes, is safe and works to preserve and/or improve vision and other symptoms of XLRP.
Sponsor: Beacon Therapeutics
Check if you qualify for this retinitis pigmentosa clinical trial in Durham, NC
If you're searching for retinitis pigmentosa treatment options in Durham, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced retinitis pigmentosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.